Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Deals are abound!!!!

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Aug 05, 2022 11:52pm

218 Views

Post# 34875938

RE:RE:RE:RE:RE:RE:RE:Deals are abound!!!!

The thing here is Matt has poured his life into this and I dont think he is going to sell at this time. if the revenue projections are correct they would see close to 5B in 2025. if that is even close I would not sell the company for anything less than 50B if I were him. the one issue is.... can he hold out until he gets that revenue stream. the stock price would obviously go up dramatically if that were to occur. I think matt wants to be another Pfizer... not sell to Pfizer. thoughts??

<< Previous

Bullboard Posts

Next >>

The deep connection between mining and First Nations in Canada